Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of colitis in signal transducers and activators of transcription 6-deficient T-cell receptor alpha-deficient mice: a potential role of signal transducers and activators of transcription 6-independent interleukin-4 signaling for the generation of Th2-biased pathological CD4+ betabetaT cells.
Okuda Y, Takahashi I, Kim JK, Ohta N, Iwatani K, Iijima H, Kai Y, Tamagawa H, Hiroi T, Kweon MN, Kawano S, Takeda K, Akira S, Sasaki Y, Hori M, Kiyono H. Okuda Y, et al. Among authors: iwatani k. Am J Pathol. 2003 Jan;162(1):263-71. doi: 10.1016/s0002-9440(10)63817-5. Am J Pathol. 2003. PMID: 12507909 Free PMC article.
Predicting pathological upstaging after radical nephroureterectomy in patients with upper tract urothelial carcinoma: results from a multicenter cohort study.
Yamaguchi R, Kagawa H, Yoshihara K, Yamamoto S, Hara S, Miyajima K, Enei Y, Fukuokaya W, Iwatani K, Imai Y, Atsuta M, Mori K, Igarashi T, Aikawa K, Yanagisawa T, Kimura S, Tashiro K, Tsuzuki S, Ishii G, Higuchi T, Sato S, Yamada Y, Furuta A, Shimomura T, Kimura T, Miki J, Urabe F. Yamaguchi R, et al. Among authors: iwatani k. Transl Androl Urol. 2024 Nov 30;13(11):2384-2395. doi: 10.21037/tau-24-357. Epub 2024 Nov 27. Transl Androl Urol. 2024. PMID: 39698572 Free PMC article.
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis.
Yanagisawa T, Mori K, Matsukawa A, Kawada T, Katayama S, Laukhtina E, Rajwa P, Quhal F, Pradere B, Fukuokaya W, Iwatani K, Afferi L, Marcq G, Mertens LS, Gallioli A, Tully KH, Caño-Velasco J, Subiela JD, Abu-Ghanem Y, Grobet-Jeandin E, Del Giudice F, Pichler R, Teoh JY, Moschini M, Krajewski W, Miki J, Shariat SF, Kimura T; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Yanagisawa T, et al. Among authors: iwatani k. Target Oncol. 2024 Nov 13. doi: 10.1007/s11523-024-01114-4. Online ahead of print. Target Oncol. 2024. PMID: 39535690
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan Consortium.
Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Fujimoto S, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Inamoto T, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: iwatani k. Int J Clin Oncol. 2025 Jan;30(1):123-133. doi: 10.1007/s10147-024-02649-2. Epub 2024 Oct 28. Int J Clin Oncol. 2025. PMID: 39467994
Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessment.
Imai Y, Urabe F, Sadakane I, Oguchi T, Iwatani K, Murakami M, Tashiro K, Aoki M, Sato S, Takahashi H, Tsuzuki S, Miki K, Kimura T. Imai Y, et al. Among authors: iwatani k. Transl Androl Urol. 2024 Sep 30;13(9):2027-2035. doi: 10.21037/tau-24-235. Epub 2024 Sep 26. Transl Androl Urol. 2024. PMID: 39434761 Free PMC article.
Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study.
Hara S, Urabe F, Tashiro K, Goto Y, Iwamoto Y, Ohtsuka T, Fukuokaya W, Imai Y, Iwatani K, Atsuta M, Mori K, Igarashi T, Aikawa K, Yanagisawa T, Kimura S, Murakami M, Tsuzuki S, Yanada BA, Hata K, Furuta A, Yamada H, Miki J, Kimura T; JIKEI-YAYOI Collaborative Group. Hara S, et al. Among authors: iwatani k. Jpn J Clin Oncol. 2024 Oct 19:hyae146. doi: 10.1093/jjco/hyae146. Online ahead of print. Jpn J Clin Oncol. 2024. PMID: 39426804
A case of pagetoid spread of urothelial carcinoma with notable reduction achieved through enfortumab vedotin, resulting in complete surgical resection.
Tokuoka K, Muramoto K, Sakanaka K, Yoshihara K, Yamamoto S, Imai Y, Iwatani K, Tashiro K, Murakami M, Harada T, Hayashimoto T, Umemori M, Kimura T, Shimomura T, Urabe F. Tokuoka K, et al. Among authors: iwatani k. Int Cancer Conf J. 2024 Aug 31;13(4):510-514. doi: 10.1007/s13691-024-00720-3. eCollection 2024 Oct. Int Cancer Conf J. 2024. PMID: 39398921
153 results